With one eye on the future

Carlos Caldas; Maria Rescigno; Samra Turajlic; Anant Madabhushi; Zemin Zhang; Piro Lito; Christine E Brown; Klaus Pantel; John Haanen; Narjust Duma

doi:10.1016/j.ccell.2022.02.019

With one eye on the future

Cancer Cell. 2022 Mar 14;40(3):221-225. doi: 10.1016/j.ccell.2022.02.019.

Authors

Carlos Caldas, Maria Rescigno, Samra Turajlic, Anant Madabhushi, Zemin Zhang, Piro Lito, Christine E Brown, Klaus Pantel, John Haanen, Narjust Duma

PMID: 35290781
DOI: 10.1016/j.ccell.2022.02.019

Abstract

In the past 20 years we have seen the rise of a new era of cancer research that moved its focus away from the cancer cell itself and revealed a complexity of interactions, both within the tumor and with the host, that ultimately dictate the evolution and progression of the disease. We have witnessed the development of immunotherapies that changed the fate of many patients and new diagnostic strategies with the potential of changing clinical practice. In this article, several experts discuss what lies ahead.

MeSH terms

Humans
Immunotherapy*
Neoplasms* / therapy

Abstract

MeSH terms

Grants and funding